CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greulich, H.
Right arrow Articles by Hanafusa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greulich, H.
Right arrow Articles by Hanafusa, H.

Cell Growth & Differentiation, Vol 7, Issue 11 1443-1451, Copyright © 1996 by American Association of Cancer Research


ARTICLES

A role for Ras in v-Crk transformation

H Greulich and H Hanafusa
Laboratory of Molecular Oncology, Rockefeller University, New York, New York 10021, USA.

The v-crk oncogene, identified as the transforming gene of the CT10 avian sarcoma virus, encodes an adaptor protein capable of transforming chicken embryo fibroblasts (CEFs). Because the Src homology 3 domain of v-Crk is capable of binding the Ras family guanine nucleotide exchange factors Sos and C3G, the contribution of cellular Ras to signaling by v-Crk was evaluated. NIH-3T3 cell lines stably expressing the v-crk oncogene exhibited a transformed phenotype similar to that of CT10-infected CEFs. Treatment of these cells with a farnesylation inhibitor, as well as coexpression of dominant negative Ras, caused morphological reversion of the v-Crk NIH-3T3 cells. Dominant negative Ras expression also inhibited colony formation in soft agar without affecting tyrosine phosphorylation of cellular proteins. Although elevation of basal Erk activity could be demonstrated in v-Crk-transformed CEFs, no significant elevation of basal Erk activity was observed in the v-Crk-transformed NIH-3T3 cells. This suggests that v-Crk requires Ras function for transformation of NIH-3T3 cells and may utilize a Ras effector other than Erk to maintain the transformed phenotype.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. Akagi, K. Murata, T. Shishido, and H. Hanafusa
v-Crk Activates the Phosphoinositide 3-Kinase/AKT Pathway by Utilizing Focal Adhesion Kinase and H-Ras
Mol. Cell. Biol., October 15, 2002; 22(20): 7015 - 7023.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
M. Tsuda, S. Tanaka, H. Sawa, H. Hanafusa, and K. Nagashima
Signaling Adaptor Protein v-Crk Activates Rho and Regulates Cell Motility in 3Y1 Rat Fibroblast Cell Line
Cell Growth Differ., March 1, 2002; 13(3): 131 - 139.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Hemmeryckx, A. van Wijk, A. Reichert, V. Kaartinen, Ron de Jong, P. K. Pattengale, I. Gonzalez-Gomez, J. Groffen, and N. Heisterkamp
Crkl Enhances Leukemogenesis in BCR/ABL P190 Transgenic Mice
Cancer Res., February 1, 2001; 61(4): 1398 - 1405.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Akagi, T. Shishido, K. Murata, and H. Hanafusa
v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation
PNAS, June 20, 2000; 97(13): 7290 - 7295.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Liu, A. A. Thant, F. Kikkawa, H. Kurata, S. Tanaka, A. Nawa, S. Mizutani, S. Matsuda, H. Hanafusa, and M. Hamaguchi
The Ras-Mitogen-activated Protein Kinase Pathway Is Critical for the Activation of Matrix Metalloproteinase Secretion and the Invasiveness in v-crk-transformed 3Y1
Cancer Res., May 1, 2000; 60(9): 2361 - 2364.
[Abstract] [Full Text]


Home page
BloodHome page
C.-S. Shi, J. Tuscano, and J. H. Kehrl
Adaptor proteins CRK and CRKL associate with the serine/threonine protein kinase GCKR promoting GCKR and SAPK activation
Blood, February 1, 2000; 95(3): 776 - 782.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Y. Nosaka, A. Arai, N. Miyasaka, and O. Miura
CrkL Mediates Ras-dependent Activation of the Raf/ERK Pathway through the Guanine Nucleotide Exchange Factor C3G in Hematopoietic Cells Stimulated with Erythropoietin or Interleukin-3
J. Biol. Chem., October 15, 1999; 274(42): 30154 - 30162.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
S. Ishimaru, R. Williams, E. Clark, H. Hanafusa, and U. Gaul
Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1
EMBO J., January 4, 1999; 18(1): 145 - 155.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. A. Feshchenko, W. Y. Langdon, and A. Y. Tsygankov
Fyn, Yes, and Syk Phosphorylation Sites in c-Cbl Map to the Same Tyrosine Residues That Become Phosphorylated in Activated T Cells
J. Biol. Chem., April 3, 1998; 273(14): 8323 - 8331.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. L. Klemke, J. Leng, R. Molander, P. C. Brooks, K. Vuori, and D. A. Cheresh
CAS/Crk Coupling Serves as a "Molecular Switch" for Induction of Cell Migration
J. Cell Biol., February 23, 1998; 140(4): 961 - 972.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
V. A. Blakesley, D. Beitner-Johnson, J. R. Van Brocklyn, S. Rani, Z. Shen-Orr, B. S. Stannard, S. Spiegel, and D. LeRoith
Sphingosine 1-Phosphate Stimulates Tyrosine Phosphorylation of Crk
J. Biol. Chem., June 27, 1997; 272(26): 16211 - 16215.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Tanaka, T. Ouchi, and H. Hanafusa
Downstream of Crk adaptor signaling pathway: Activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G
PNAS, March 18, 1997; 94(6): 2356 - 2361.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Akagi, T. Shishido, K. Murata, and H. Hanafusa
v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation
PNAS, June 20, 2000; 97(13): 7290 - 7295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.